(Q46207519)

20 December 2017

title

Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: a pilot study (English)

1 reference

20 December 2017

0 references

0 references

1 reference

Nicolas Tsavaris

1

1 reference

20 December 2017

Petros Kopterides

2

1 reference

20 December 2017

Christos Kosmas

3

1 reference

20 December 2017

Athina Efthymiou

4

1 reference

20 December 2017

Hlias Skopelitis

5

1 reference

20 December 2017

Antonios Dimitrakopoulos

6

1 reference

20 December 2017

Eyterpi Pagouni

7

1 reference

20 December 2017

Dimitrios Pikazis

8

1 reference

20 December 2017

Panagiotis-Vasilis Zis

9

1 reference

20 December 2017

Christos Koufos

10

1 reference

20 December 2017

publication date

1 November 2008

1 reference

20 December 2017

published in

Pain Medicine

1 reference

20 December 2017

volume

9

1 reference

20 December 2017

issue

8

1 reference

20 December 2017

page(s)

1209-1216

1 reference

20 December 2017

An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Contemporary management of neuropathic pain for the primary care physician

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Neurologic complications of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Peripheral neuropathies and neurotrophic factors: animal models and clinical perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Characterization of the effects of gabapentin and 3-isobutyl-gamma-aminobutyric acid on substance P-induced thermal hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGF treatment schedule: in vitro study of adult rat sympathetic ganglion explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Clinical trials of nimodipine as a potential neuroprotector in ovarian cancer patients treated with cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00325.X

10.1111/J.1526-4637.2007.00325.X

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017